Sunday, August 18, 2019

Uloric Risks and Alternatives

Since the FDA added a boxed warning to Uloric for elevated risk of fatal cardiovascular events in February 2019, physicians and patients who take Uloric for gout are reconsidering the treatment. Because of the possibility of death, Uloric has since been removed as a first line treatment for gout. Heart-related deaths among...